National Cancer Institute
Found 21 results for your search:
Total relevant funding to Wilm's Tumor for this search:
$4,673,401
Fiscal Year FY 2017
Cancer Type [Wilm's Tumor]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 21 of 21 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
Children's Oncology Group Statistics and Data Center 5U10CA180899-04 $7,008,867 $700,887 DEVIDAS, MEENAKSHI UNIVERSITY OF FLORIDA
2
COG NCTN Network Group Operations Center 3U10CA180886-04S1 $1,393,520 $83,611 ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA
3
COG NCTN Network Group Operations Center 5U10CA180886-04 $22,547,116 $1,352,827 ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA
4
COG NCTN Solid Malignancy Integrated Translational Science Center 5U10CA180884-04 $400,000 $80,000 ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA
5
DF/HCC Kidney Cancer SPORE 5P50CA101942-13 $2,300,000 $276,000 MCDERMOTT, DAVID BETH ISRAEL DEACONESS MEDICAL CENTER
6
Growth-Differentiation Factors in Organogenesis ZIA BC 005093 $748,932 $337,020 Perantoni, Alan CCR (NCI)
7
Identification of Genetic Factors Associated with Infectious Diseases ZIA BC 010297 $313,024 $31,302 Winkler, Cheryl CCR (NCI)
8
Identification of Novel Mutations In Pediatric Cancers ZIA BC 010998 $511,155 $25,558 Khan, Javed CCR (NCI)
9
Late Effects of Treatment in Wilms Tumor Survivors and Offspring 3R01CA054498-25S1 $44,259 $44,259 LEISENRING, WENDY FRED HUTCHINSON CANCER RESEARCH CENTER
10
Oncogenic Met Signaling in Urologic Malignancies ZIA BC 011124 $356,352 $7,127 Bottaro, Donald CCR (NCI)
11
Regulation of the LIN28/let-7 pathway in cancer 1R01CA211328-01 $404,888 $404,888 GREGORY, RICHARD BOSTON CHILDREN'S HOSPITAL
12
Research Management and Support RMS ES 2017 $326,124,631 $21,000 N/A National Institutes of Health
13
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor 1R01CA219013-01 $632,028 $632,028 KALAPURAKAL, JOHN NORTHWESTERN UNIVERSITY AT CHICAGO
14
The Robert H. Lurie Comprehensive Cancer Center 3P30CA060553-23S1 $204,369 $6,131 PLATANIAS, LEONIDAS NORTHWESTERN UNIVERSITY AT CHICAGO
15
The Robert H. Lurie Comprehensive Cancer Center 3P30CA060553-23S2 $57,797 $1,734 PLATANIAS, LEONIDAS NORTHWESTERN UNIVERSITY AT CHICAGO
16
The Robert H. Lurie Comprehensive Cancer Center 3P30CA060553-23S3 $79,482 $2,384 PLATANIAS, LEONIDAS NORTHWESTERN UNIVERSITY AT CHICAGO
17
The Robert H. Lurie Comprehensive Cancer Center 5P30CA060553-23 $4,865,652 $145,970 PLATANIAS, LEONIDAS NORTHWESTERN UNIVERSITY AT CHICAGO
18
The role of Lin28/let 7 pathway in Wilms' tumor 5F99CA212487-02 $31,994 $31,994 YERMALOVICH, ALENA HARVARD UNIVERSITY
19
The role of PLAG1 in Wilms tumor formation 1K08CA207849-01A1 $157,185 $157,185 CHEN, KENNETH UT SOUTHWESTERN MEDICAL CENTER
20
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer 5P50CA196516-02 $2,300,000 $322,000 BRUGAROLAS, JAMES UT SOUTHWESTERN MEDICAL CENTER
21
Tumor Microenvironment in Cancer Progression ZIA BC 011332 $474,811 $9,496 Kaplan, Rosandra CCR (NCI)
Total relevant funding to Wilm's Tumor for this search: $4,673,401
Showing 1 - 21 of 21 results
Go to top